Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Clinical, Histopathological and Molecular Characteristics of Metastatic Breast Cancer in North-Eastern Kazakhstan: a 10 Year Retrospective Study

  • Published : 2016.10.01
⟨ Previous Next ⟩

Abstract

Background: Breast cancer (BC) is the top cancer among women worldwide and has been the most frequent malignancy among Kazakhstan women over the past few decades. Information on clinical and histopathological features of metastatic breast cancer (MBC), as well as the distribution of molecular subtypes is limited for Kazakh people. Materials and Methods: The present observational retrospective study was carried out at Regional Oncologic Dispensaries in the North-East Region of Kazakhstan (in Semey and Pavlodar cities). Сlinical and histopathological data were obtained for a total of 570 MBC patients in the 10 year period from 2004-2013, for whom data on molecular subtype were available for 253. Data from hospital charts were entered into SPSS 20 for analysis by one-way ANOVA analysis of associations of different variables with 1-5 year survival. Pearson correlation and linear regression models were used to examine the relation between parameters with a p-value < 0.05 considered statistically significant. Results: No significant relationships were evident between molecular subtype and survival, site of metastases, stage or ethnicity. Young females below the age of 44 were slightly more likely to have triple negative lesions. While the ductal type greatly predomonated, luminal A and B cases had a higher percentage with lobular morphology. Conclusions: In this select group of metastatice brease cancer, no links were noted for survival with molecular subtype, in contrast to much of the literature.

Keywords

References

  1. Alnegheimish NA, Alshatwi RA, Alhefdhi RM, et al (2016). Molecular subtypes of breast carcinoma in Saudi Arabia. A retrospective study. Saudi Med J, 37, 506-12. https://doi.org/10.15537/smj.2016.5.15000
  2. Bekmukhambetov Y, Imangazina Z, Jarkenov T, et al (2015). Cancer incidence and mortality data in Aktobe, West Kazakhstan, 2000-2010. Asian Pac J Cancer Prev, 16, 2379-83. https://doi.org/10.7314/APJCP.2015.16.6.2379
  3. Beysebayev E, Bilyalova Z, Kozhakeeva L, Baissalbayeva A, Abiltayeva A (2015a). Spatial and temporal epidemiological assessment of breast cancer incidence and mortality in Kazakhstan, 1999-2013. Asian Pac J Cancer Prev, 16, 6795. https://doi.org/10.7314/APJCP.2015.16.15.6795
  4. Beysebayev E, Tulebayev K, Meymanalyev T (2015b). Breast cancer diagnosis by mammography in Kazakhstan - staging results of breast cancer with double reading. Asian Pac J Cancer Prev, 13, 2341-4.
  5. Cherenkov VG, Petrov AB, Ivanchenko VV, Tverezovskii SA, Frumkin BB (2013). Diagnosis and morphologic verification of tumors detected by mammography screening. Vopr Onkol, 59, 118-22 (in Russian).
  6. Chuangsuwanich T, Pongpruttipan T, O-Charoenrat P, et al (2014). Clinicopathologic features of breast carcinomas classified by biomarkers and correlation with microvessel density and VEGF expression: a study from Thailand. Asian Pac J Cancer Prev, 15, 1187-92. https://doi.org/10.7314/APJCP.2014.15.3.1187
  7. Chukmaitov A, Wan TT, Menachemi N, Cashin C (2008). Breast cancer knowledge and attitudes toward mammography as predictors of breast cancer preventive behavior in Kazakh, Korean, and Russian women in Kazakhstan. Int J Public Health, 53, 123-30. https://doi.org/10.1007/s00038-008-7001-9
  8. Denisov EV, Litviakov NV, Zavyalova MV, et al (2014). Intratumoral morphological heterogeneity of breast cancer: neoadjuvant chemotherapy efficiency and multidrug resistance gene expression. Sci Rep, 4, 4709.
  9. Dudarev A, Chupakhin V, Odland J (2013). Cancer incidence and mortality in Chukotka, 1999-2010. Int J Circumpolar Health, 72, 20470. https://doi.org/10.3402/ijch.v72i0.20470
  10. Elkablawy MA, Albasri AM, Hussainy AS, Nouh MM, Alhujaily A (2015). Molecular profiling of breast carcinoma in Almadinah, KSA: immunophenotyping and clinicopathological correlation. Asian Pac J Cancer Prev, 16, 7819-24. https://doi.org/10.7314/APJCP.2015.16.17.7819
  11. Ferlay J, Soerjomataram I, Dikshit R, et al (2015). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 136, 359-86. https://doi.org/10.1002/ijc.29210
  12. Forman D, Bray F, Brewster DH, et al (2014). Cancer incidence in five continents volume x (IARC scientific publications No. 164). IARC: Lyon.
  13. Guo L, Hou X, Dilimina Y, Wang B (2014). Expression of $ER{\beta}$, $ER{\alpha}$ and Her-2 and distribution of molecular subtypes in Uygur and Han patients with breast cancer. Exp Ther Med, 7, 1077-82. https://doi.org/10.3892/etm.2014.1596
  14. Hashmi AA, Edhi MM, Naqvi H, Khurshid A, Faridi N (2014). Molecular subtypes of breast cancer in South Asian population by immunohistochemical profile and Her2neu gene amplification by FISH technique: association with other clinicopathologic parameters. Breast J, 20, 578-85. https://doi.org/10.1111/tbj.12329
  15. Igisinov N (2004). Ethnic and age variation of cancer of the reproductive system in women of Kyrgyzstan. Asian Pac J Cancer Prev, 5, 217-22.
  16. Igisinov N, Kokteubaeva N, Kudaibergenova I (2005). Epidemiology of breast cancer in females of reproductive age in Kyrgyzstan. Asian Pac J Cancer Prev, 6, 37-40.
  17. Igissinov N, Igissinov S, Moore MA, et al (2011). Trends of prevalent cancer incidences in the Aral Sea area of Kazakhstan. Asian Pac J Cancer Prev, 12, 2299-303.
  18. Jia WJ, Jia HX, Feng HY, et al (2014). Her-2 enriched tumors have the highest risk of local recurrence in Chinese patients treated with breast conservation therapy. Asian Pac J Cancer Prev, 15, 315-20. https://doi.org/10.7314/APJCP.2014.15.1.315
  19. Kadivar M, Mafi N, Joulaee A, et al (2012). Breast cancer molecular subtypes and association with clinicopathological characteristics in Iranian women, 2002-2011. Asian Pac J Cancer Prev, 13, 1881-6. https://doi.org/10.7314/APJCP.2012.13.5.1881
  20. Kaplan MA, Arslan UY, Isikdogan A, et al (2016). Biological subtypes and distant relapse pattern in breast cancer patients after curative surgery (Study of anatolian society of medical oncology). Breast Care, 11, 248-52. https://doi.org/10.1159/000448186
  21. Kutikhin A, Yuzhalin A, Brailovskiy V, et al (2012). Analysis of cancer incidence and mortality in the industrial region of South-East Siberia from 1991 through 2010. Asian Pac J Cancer Prev, 13, 5189-93. https://doi.org/10.7314/APJCP.2012.13.10.5189
  22. Liu YH, Wang OC, Chen ED, et al (2015). Unexpected features of breast cancer subtype. World J Surg Oncol, 13, 249. https://doi.org/10.1186/s12957-015-0665-8
  23. Mehdi I, Monem AA, Al Bahrani B, Ramadhan FA (2014a). Breast cancer molecular subtypes in Oman: correlation with age, histology, and stage distribution - analysis of 542 cases. Gulf J Oncolog, 1, 38-48.
  24. Moore MA, Eser S, Igisinov N, et al (2010). Cancer epidemiology and control in North-West Asia - past, present and future. Asian Pac J Cancer Prev, 11, 17-32.
  25. Najafi B, Anvari S, Roshan ZA (2013). Disease free survival among molecular subtypes of early stage breast cancer between 2001 and 2010 in Iran. Asian Pac J Cancer Prev, 14, 5811-6. https://doi.org/10.7314/APJCP.2013.14.10.5811
  26. Poddubnaya I, Axel E, Kipriyanova N, et al (2007). Component analysis of cancer incidence population (Yakutsk, 1990-2003). Siberian J Oncol, 2, 55-63.
  27. Shibuta K, Ueo H, Furusawa H, et al (2011). The relevance of intrinsic subtype to clinicopathological features and prognosis in 4,266 Japanese women with breast cancer. Breast Cancer, 18, 292-8. https://doi.org/10.1007/s12282-010-0209-6
  28. Shim HJ, Kim SH, Kang BJ, et al (2014). Breast cancer recurrence according to molecular subtype. Asian Pac J Cancer Prev, 15, 5539-44. https://doi.org/10.7314/APJCP.2014.15.14.5539
  29. Tamaki M, Kamio T, Kameoka S, Kojimahara N, Nishikawa T (2013). The relevance of the intrinsic subtype to the clinicopathological features and biomarkers in Japanese breast cancer patients. World J Surg Oncol, 11, 293. https://doi.org/10.1186/1477-7819-11-293
  30. Thapa B, Singh Y, Sayami P, et al (2013). Breast cancer in young women from a low risk population in Nepal. Asian Pac J Cancer Prev, 14, 5095-9. https://doi.org/10.7314/APJCP.2013.14.9.5095
  31. Tichy JR, Lim E, Anders CK (2013). Breast cancer in adolescents and young adults: a review with a focus on biology. J Natl Compr Canc Netw, 11, 1060-9. https://doi.org/10.6004/jnccn.2013.0128
  32. Widodo I, Dwianingsih EK, Triningsih E, Utoro T, Soeripto G (2014) . Clinicopathological features of Indonesian breast cancers with different molecular subtypes. Asian Pac J Cancer Prev, 15, 6109-13. https://doi.org/10.7314/APJCP.2014.15.15.6109
  33. Zavyalova MV, Denisov EV, Tashireva LA, et al (2013). Phenotypic drift as a cause for intratumoral morphological heterogeneity of invasive ductal breast carcinoma not otherwise specified. Biores Open Access, 2, 148-54. https://doi.org/10.1089/biores.2012.0278
  34. Zavyalova M, Vtorushin S, Telegina N, et al (2016). Clinicopathological features of nonspecific invasive breast cancer according to its molecular subtypes. Exp Oncol, 38, 122-7.